FDA Investigator Narong Chamkasem, PhD
Narong Chamkasem, PhD has inspections in 2 countries as of 12 May 2023. Narong Chamkasem, PhD has collaborated with a combined 1036 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
12 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
India
Co-Investigator(s):
Abby E Pelletier,
Abdollah Koolivand,
Amy H Ruble,
Ann L Demarco,
Arsen Karapetyan,
Bonita S Chester,
Brandon C Heitmeier,
Buford,
CDR Thomas R Berry, PPh,
Clifton L Randell,
Constance Y Fears,
Debra I Love,
Demario L Walls,
Desiree D Clark,
Diane P Goyette,
Dr. Barbara D Paul, PhD,
Eileen A Liu,
Frank Wackes,
Jamie L Port,
Jared P Stevens,
Jessica L Pressley,
June P Page,
Justin A Boyd,
Kathleen D Culver,
Kemejumaka N Opara,
Kevin P Foley,
Larry K Hampton,
Lucila B Nwatu,
Margaret M Annes,
Marie F Morin,
Mary Jeanet Mcgarry,
Matthew B Casale,
Melanie M Walker,
Neil J Bonzagni, PhD MPH,
Nicole A Lloyd,
Noreen Muniz,
Postelle Birch Smith,
Postelle D Birch Smith,
Rachael L Cook,
Randy L Clarida,
Rita K Kabaso,
Robert C Coleman,
Sangeeta M Khurana, PhD,
Sangeeta M Rataul,
Saundrea A Munroe,
Sayeeda Hdabe,
Seneca D Toms,
Sharna D Pratt,
Song Y Lavalais,
Sonya M Edmonds,
Stephen D Brown,
Steven P Donald,
Thomas J Arista,
Tonia F Bernard,
Torrance J Slayton,
Unnee Ranjan,
Vilmary Negron Rodriguez,
Vincent Thomas,
Yasamin Ameri
Narong Chamkasem, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2014 | EIR | Ajinomoto Health & Nutrition North America, Inc. - EIR, 2014-05-21 |
April, 2015 | FDA 483 | Intas Pharmaceuticals Limited - Form 483, 2015-04-07 |
July, 2016 | FDA 483 | Nephron Sterile Compounding Center, LLC - Form 483, 2016-07-06 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more